Dr. Y. Tony Yang | Professor
The George Washington University

Y. Tony Yang, ScD, LLM, MPH, is an endowed professor (with tenure) in health policy and Associate Dean for Health Policy and Population Science at George Washington University School of Nursing. He also holds a joint appointment at the Milken Institute School of Public Health in the Department of Health Policy and Management. He is a Program Lead (Cancer Control and Health Equity) with the GW Cancer Center and an affiliated faculty with the District of Columbia Center for AIDS Research (DC CFAR), Jacobs Institute of Women's Health, and Institute for Data, Democracy & Politics. His scholarship explores the effects of law and policy on healthcare delivery and population health outcomes. He was a postdoctoral researcher at the Massachusetts Institute of Technology, an FDA Regulatory Science Fellow (jointly organized by the National Academy of Medicine), and an AcademyHealth Health Policy Fellow (jointly organized by the CDC-National Center of Health Statistics). Dr. Yang has authored more than 150 peer-reviewed articles. His first-authored work has appeared in leading general medicine (including New England Journal of Medicine, JAMA, Lancet), oncology (including Lancet Oncology, Journal of Clinical Oncology), pediatrics (including JAMA Pediatrics, Pediatrics), health policy and services (including Health Affairs, Milbank Quarterly, Medical Care), public health (including American Journal of Public Health, Public Health Reports), and health law (including Journal of Law, Medicine & Ethics, Food and Drug Law Journal) journals. He is the lead author of a book about vaccine policy published by Springer in 2023. The impact of his scholarship is observable in media coverage on outlets such as CNN, Fox News, National Public Radio, New York Times, Wall Street Journal, Washington Post, LA Times, San Francisco Chronicle, Chicago Tribune, Philadelphia Inquirer, Boston Globe, and USA Today. Dr. Yang received an Early Career Award for Excellence from the American Public Health Association. He is a Distinguished Fellow of the National Academies of Practice. Dr. Yang has been awarded over $5.5 million in U.S. federal grants as a principal investigator, including an active 4-year R01 from NIH-National Cancer Institute. Various foundation funders have supported him as a principal investigator, including The Robert Wood Johnson Foundation (Policy for Action, Interdisciplinary Research Leaders, and Public Health Law Research). He is a member of AcademyHealth Education Council. He holds graduate degrees in Public Health (Harvard), Health Policy and Management (Harvard), and Law (University of Pennsylvania).